BrightStar Wisconsin Foundation announced that it has invested in Stem Pharm Inc., a Madison biotechnology company focused on creating adult stem cell-derived neural organoids, which are miniature, simplified versions of an organ produced in vitro, to evaluate drug treatments for neural diseases.
BrightStar is a 501(c)(3) nonprofit foundation created to facilitate job creation and increase Wisconsin’s economic activity by deploying donated funds into equity in early-stage, rapidly growing companies.
